- CH₣14.57bn
- CH₣17.60bn
- $10.38bn
- 65
- 25
- 53
- 43
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 12.58 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | -7.75% | ||
| Dividend Yield (f) | 2.03% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.16 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 293.36 | ||
| Price to Sales | 1.7 | ||
| EV to EBITDA | 26.85 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 2.21% | ||
| Return on Equity | n/a | ||
| Operating Margin | 2.89% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 9,658 | 9,678 | 9,306 | 9,979 | 10,384 | 10,847.18 | 11,564.97 | 1.83% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | -6.37 | -0.89 | +9.63 | +32.61 | -18.39 | +20.23 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Sandoz Group AG is a Switzerland based company which is active in healthcare technology industry. The Company operates in two businesses, Generics and Biosimilars. Generics business develops, manufacture and market active ingredients and finished dosage forms of small molecule pharmaceuticals, finished dosage forms of anti-infectives and active pharmaceutical ingredients and intermediates. Biosimilars business develops, manufacture and market protein-based and other biological products which are similar to another already approved biological medicines. Company’s product portfolio comprising Generics and Biosimilars covers all therapeutic areas for patient treatment such as cardiovascular, central nervous system, oncology, anti-infectives, pain and respiratory. The Company serves customers worldwide.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- January 17th, 2022
- Public Since
- October 4th, 2023
- No. of Shareholders
- 157,641
- No. of Employees
- 23,406
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
SIX Swiss Exchange- Shares in Issue
- 430,701,660
- Address
- Suurstoffi 14, ROTKREUZ, 6343
- Web
- https://www.sandoz.com/
- Phone
- Contact
- Craig Marks
- Auditors
- KPMG AG
Latest News for SDZ
Upcoming Events for SDZ
Q1 2025 Sandoz Group AG Corporate Sales Release
Q1 2025 Sandoz Group AG Corporate Sales Call
Sandoz Group AG Annual Shareholders Meeting
Sandoz Group AG at BNP Paribas European CEO Conference
Half Year 2025 Sandoz Group AG Earnings Release
Similar to SDZ
Cosmo Pharmaceuticals NV
SIX Swiss Exchange
Curatis Holding AG
SIX Swiss Exchange
Dottikon Es Holding AG
SIX Swiss Exchange
Galenica AG
SIX Swiss Exchange
Novartis AG
SIX Swiss Exchange
FAQ
As of Today at 23:02 UTC, shares in Sandoz AG are trading at CH₣33.83. This share price information is delayed by 15 minutes.
Shares in Sandoz AG last closed at CH₣33.83 and the price had moved by +13.94% over the past 365 days. In terms of relative price strength the Sandoz AG share price has outperformed the FTSE Global All Cap Index by +11.08% over the past year.
The overall consensus recommendation for Sandoz AG is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe Sandoz AG dividend yield is 1.62% based on the trailing twelve month period.
Last year, Sandoz AG paid a total dividend of $0.66, and it currently has a trailing dividend yield of 1.62%. We do not have any data on when Sandoz AG is to next pay dividends.
We do not have data on when Sandoz AG is to next pay dividends. The historic dividend yield on Sandoz AG shares is currently 1.62%.
To buy shares in Sandoz AG you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of CH₣33.83, shares in Sandoz AG had a market capitalisation of CH₣14.57bn.
Here are the trading details for Sandoz AG:
- Country of listing: Switzerland
- Exchange: SWX
- Ticker Symbol: SDZ
Based on an overall assessment of its quality, value and momentum Sandoz AG is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Sandoz AG is CH₣44.04. That is 30.17% above the last closing price of CH₣33.83.
Analysts covering Sandoz AG currently have a consensus Earnings Per Share (EPS) forecast of $3.05 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Sandoz AG. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -8.93%.
As of the last closing price of CH₣33.83, shares in Sandoz AG were trading -10.44% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Sandoz AG PE ratio based on its reported earnings over the past 12 months is 12.58. The shares last closed at CH₣33.83.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Sandoz AG's directors